Exploratory, Phase II Controlled Trial of Shiunko Ointment Local Application Twice a Day for 4 Weeks in Ethiopian Patients with Localized Cutaneous Leishmaniasis

Evidence-based Complementary and Alternative Medicine

Volumn 2016, Issue , 2016, Pages

  Na Bangchang, Kesara ^a   Ahmed, Oumer ^b   Hussein, Jemal ^b   Hirayama, Kenji ^c   Kongjam, Panida ^a   Aseffa, Abraham ^b   Karbwang, Juntra ^c  

^a THAMMASAT UNIVERSITY   (Thailand)

^b ARMAUER HANSEN RESEARCH INSTITUTE   (Ethiopia)

^c NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPROTOZOAL AGENT; PLACEBO; SHIUNKO OINTMENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BURNING SENSATION; CONJUNCTIVITIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ETHIOPIAN; FEMALE; FOLLOW UP; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PAIN; PHASE 2 CLINICAL TRIAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SECONDARY INFECTION; SIDE EFFECT; SKIN LEISHMANIASIS; TREATMENT OUTCOME; WOUND CLOSURE;

EID: 84971467973     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2016/5984709     Document Type: Article

References (20)

1. J. Alvar, I. D. Vélez, C. Bern et al., "Leishmaniasis worldwide and global estimates of its incidence, " PLoS ONE, vol. 7, no. 5, Article ID e35671, 12 pages, 2012.
2. A. Hailu, T. Di Muccio, T. Abebe, M. Hunegnaw, P. A. Kager, and M. Gramiccia, "Isolation of Leishmania tropica from an Ethiopian cutaneous leishmaniasis patient, " Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 100, no. 1, pp. 53-58, 2006.
3. A. D. Bryceson, "Diffuse cutaneous leishmaniasis in Ethiopia. II. Treatment, " Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 64, no. 3, pp. 369-379, 1970.
4. V. Padovese, M. Terranova, L. Toma, G. A. Barnabas, and A. Morrone, "Cutaneous and mucocutaneous leishmaniasis in Tigray, northern Ethiopia: clinical aspects and therapeutic concerns, " Transactions of the Royal Society of TropicalMedicine and Hygiene, vol. 103, no. 7, pp. 707-711, 2009.
5. F. Tilahun, W. Alemu, and G. Mulatu, "Magnitude and associated factors of cutaneous leishmaniasis; in Mekelle city, Ayder referral hospital, Tigray, Northern Ethiopia, 2014, " Clinical Medicine Research, vol. 3, no. 6, pp. 189-199, 2014.
6. E. Negera, E. Gadisa, L. Yamuah et al., "Outbreak of cutaneous leishmaniasis in Silti woreda, Ethiopia: risk factor assessment and causative agent identification, " Transactions of the Royal Society of TropicalMedicine andHygiene, vol. 102, no. 9, pp. 883-890, 2008.
7. E. Negera, E. Gadisa, J. Hussein et al., "Treatment response of cutaneous leishmaniasis due to Leishmania aethiopica to cryotherapy and generic sodium stibogluconate from patients in Silti, Ethiopia, " Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 106, no. 8, pp. 496-503, 2012.
8. WHO, Report of the Fifth Consultative Meeting on Leishmania/ HIV Coinfection, Addis Ababa, Ethiopia, 2007, http://www. who. int/leishmaniasis/resources/Leishmaniasis hiv coinfection5. pdf.
9. I. Andújar, J. L. Ríos, R. M. Giner, and M. C. Recio, "Pharmacological properties of shikonin-a review of literature since 2002, " Planta Medica, vol. 79, no. 18, pp. 1685-1697, 2013.
10. The Japanese Health Sciences Foundation, European patent application number 05766412. 0, http://www. jhsf. or. jp/English/ index e. html.
11. U. Gonzalez, M. Pinart, L. Reveiz, and J. Alvar, "Interventions forOldWorld cutaneous leishmaniasis, "TheCochraneDatabase of Systematic Reviews, no. 4, Article ID CD005067, 2008.
12. National Institute ofHealth andNationalCancer Institute. USA, Common Terminology Criteria for Adverse Events (CTCAE) Version 4, 2009, (v4. 03, 2010).
13. M. Utaile, A. Kassahun, T. Abebe, and A. Hailu, "Susceptibility of clinical isolates of Leishmania aethiopica to miltefosine, paromomycin, amphotericin B and sodium stibogluconate using amastigote-macrophage in vitro model, " Experimental Parasitology, vol. 134, no. 1, pp. 68-75, 2013.
14. R. J. S. Burchmore and M. P. Barrett, "Life in vacuoles-nutrient acquisition by Leishmaniaamastigotes, " International Journal for Parasitology, vol. 31, no. 12, pp. 1311-1320, 2001.
15. S. Sundar, "Drug resistance in Indian visceral leishmaniasis, " Tropical Medicine and International Health, vol. 6, no. 11, pp. 849-854, 2001.
16. M. Karayannopoulou, V. Tsioli, P. Loukopoulos et al., "Evaluation of the effectiveness of an ointment based on alkannins/ shikonins on second intention wound healing in the dog, " Canadian Journal of Veterinary Research, vol. 75, no. 1, pp. 42-48, 2011.
17. C.-Y. Hsiao, T.-H. Tsai, and K.-F. Chak, "The molecular basis of wound healing processes induced by lithospermi radix: a proteomics and biochemical analysis, " Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 508972, 15 pages, 2012.
18. K. F. Chak, C. Y. Hsiao, and T. Y. Chen, "A study of the effect of shiunko, a traditional Chinese herbal medicine, on fibroblasts and its implication on wound healing processes, " Advances in Wound Care, vol. 2, no. 8, pp. 448-455, 2013.
19. A. Albreht, I. Vovk, and B. Simonovska, "Addition of-lactoglobulin produces water-soluble shikonin, " Journal of Agricultural and Food Chemistry, vol. 60, no. 43, pp. 10834-10843, 2012.
20. M. Nishizawa, M. Kohno, M. Nishimura, A. Kitagawa, and Y. Niwano, "Presence of peroxyradicals in cigarette smoke and the scavenging effect of shikonin, a naphthoquinone pigment, " Chemical and Pharmaceutical Bulletin, vol. 53, no. 7, pp. 796-799, 2005.